Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
Goldman Sachs raised India’s CY26 growth forecast to 6.8% after lower crude assumptions post the US-Iran peace deal, while trimming inflation, CAD and oil import estimates.
Fairfax India has finalised a Rs 2,000 crore investment in IIFL Capital Services via preferential allotment at Rs 350 a share and an open offer, taking its stake to at least 51%.
Indoco Remedies said its Goa Plant I received EU GMP certification after a Malta Medicines Authority inspection in November 2025, strengthening its ability to supply regulated European markets.
HDFC AMC scheduled a July 15, 2026 board meeting to approve Q1 FY27 results, with a July 1-17 trading window closure and fresh sustainability-focused portfolio launch.
Transrail Lighting has won new overseas EPC transmission-line contracts in the MENA region worth ₹459 crore, lifting annual order inflow to ₹1,034 crore with ₹400 crore in L1.
India’s primary market is preparing for a stronger second half of 2026, led by draft filings and planned launches from Jio Platforms, NSE, SBI Mutual Fund and Zepto.
Bajaj Healthcare reported Q2 FY26 revenue growth and said SEC-CDSCO recommended Phase III trials for Suvorexant, while DCGI cleared Phase III trials for Cenobamate tablets.
Puravankara plans to divest its stake in Purva Ruby Properties to an ICICI Prudential-managed fund entity for an estimated ₹145 crore, with completion targeted within 45 days.
Advit Jewels IPO applicants can check allotment status on Bigshare, BSE, or NSE using PAN, application number, or demat details ahead of the June 29 finalisation.
Alembic Pharmaceuticals received final USFDA approval for oseltamivir phosphate oral suspension (6 mg/mL), a generic Tamiflu alternative, addressing a USD 27 million US market.
Alembic Pharmaceuticals received USFDA final approval for generic oseltamivir oral suspension 6 mg/ml, equivalent to Roche’s Tamiflu, targeting an estimated USD 27 million US market.
Power Grid’s board cleared a higher overall borrowing limit, an ECB plan of up to $500 million, and an SBI loan facility, with key approvals subject to shareholders.
SEBI has rejected settlement applications by Anil Ambani and Reliance Infrastructure over alleged fund routing, while related matters involving SAT challenges and a Yes Bank case continue.
Social media analysis shows most long-run Nifty gains came from overnight gaps, while intraday moves were flat to negative across multiple market cycles.
Social media chatter on a possible Union Cabinet reshuffle is putting Nirmala Sitharaman, Dharmendra Pradhan and Shaktikanta Das at the centre of market attention.
Delhi government is preparing action against Fortis Hospital, Shalimar Bagh after a magistrate-led inspection flagged alleged treatment delays, SOP lapses, and multiple building and fire-safety irregularities.